R&D and Manufacture serve as the engine,
while registration affair embodies the soul.
With professionalsm and dilgence, we regenerate through "qualty parity". Development serves as the engine for our company's sustainable growth, while registration affair represents its soul. Keeping a close eye on the international forefront, we deepen international cooperation, accurately identify and assess clinical needs, enhance our R&D and innovation capabilities, and delve deplyinto "convenient medicines for home use" while developing "reference antibiotics".
Development Goals for "Home convenient Medicines"
To establish multiple wel-known brands in the chronic disease management sector, meet the long-term medication needs of patients, develop more convenient dosage forms, establish a multi-chanel sales model encompassing both medical insurance-covered and non-medical insurance-covered products, and achieve sustained corporate growth and a leading market position.
Development Goals for "Reference Antibiotics"
To construct the most comprehensive and distincive antibiotic product pipeline, strengthen the original research (reference list drug) foundation through BD (Business Development) collaborations, leverage localized production of original drug (reference list drug) to enhance product quality and market influence.
Wonterfull is committed to open innovation, bringing together the most outstanding experts from around the world to join our development team, cre-ating synergies, and providing innovative solutions for our therapeutic and technological fields.
We have established a technological cooperation ecosystem with scientific research institutes, hospitals, and internationally renowned pharmaceutical companies.
